Surgical Oncology
Volume 18, Issue 4 , Pages 298-321 , December 2009

Surgical management of hepatocellular carcinoma: Is the jury still out?

,Accepted 19 August 2008.

References 

  1. Bosch FX, Ribes J, Clries R, Diaz M. Epidemiology of hepatocellular carcinoma. Clin Liver Dis. 2005;9:191–211
  2. Taylor-Robinson SD, Foster GR, Arora S, Hargreaves S, Thomas HC. Increase in primary liver cancer in the U.K., 1979–1994. Lancet. 1997;350:1142–1143
  3. Deuffic S, Poynard T, Buffat L, Valleron A-J. Trends in primary liver cancer. Lancet. 1998;351:214–215
  4. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med. 1999;340:745–750
  5. Okuda K, Fujimoto I, Hanai A, Urano Y. Changing incidence of hepatocellular carcinoma in Japan. Cancer Res. 1987;47:4967–4972
  6. Llovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis. 2005;2:181–200
  7. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917
  8. Llovet JM, Bustamante J, Castells A, Vilana R, Ayuso Mdel C, Sala M, et al. Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology. 1999;29:62–67
  9. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  10. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699
  11. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434–1440
  12. Greene FL, Page DL, Fleming DL. Liver including intrahepatic bile ducts. American Joint Committee on Cancer staging manual. 6th ed.. New York: Springer; 2002;145–153
  13. Bruix J, Castells A, Bosch J, Feu F, Fuster J, Garcia-Pagan JC, et al Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018–1022
  14. Noguchi T, Imai T, Mizumoto R. Preoperative assessment of surgical risk of hepatectomy in cirrhotic patients. Hepatogastroenterology. 1990;37:165–171
  15. Torzilli G, Makuuchi M, Inoue K, Takayama T, Sakamoto Y, Sugawara Y. No-mortality liver resection for hepatocellular carcinoma in cirrhotic and non-cirrhotic patients. Arch Surg. 1999;134:984–992
  16. Immamura H, Seyama Y, Kokudo N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg. 2003;138:1198–1206
  17. Shirabe K, Shimada M, Gion T, Hasegawa H, Takenaka K, Utsunomiya T, et al. Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume. J Am Coll Surg. 1999;188:304–309
  18. Kokudo N, Makuuchi M. Current role of portal vein embolization/hepatic artery chemoembolization. Surg Clin North Am. 2004;84:643–657
  19. Farges O, Belghiti J, Kianmanesh R, Regimbeau JM, Santoro R, Vilgrain V, et al. Portal vein embolization before right hepatectomy: prospective clinical trial. Ann Surg. 2003;237(2):208–217
  20. Chen MF, Jeng LB. Partial hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol. 1997;12:S329–S334
  21. Nadig DE, Wade TP, Fairchild RB, Virgo KS, Johnson FE. Major hepatic resection. Indications and results in a national hospital system from 1998 to 1992. Arch Surg. 1997;132:115–119
  22. Nonami K, Harada A, Kurokawa T, Nakao A, Takagi H. Hepatic resection for hepatocellular carcinoma. Am J Surg. 1997;173:266–291
  23. Shuto T, Hirohashi K, Kubo S, Tanaka H, Tsukamoto T, Yamamoto T, et al. Changes and results of surgical strategies for hepatocellular carcinoma: results of a 15-year study on 452 consecutive patients. Surg Today. 1998;28:1124–1129
  24. Lise M, Bacchetti S, Da Pian P, Nitti D, Pilati PL, Pigato P. Prognostic factors affecting long term outcome after liver resection for hepatocellular carcinoma: results in a series of 100 Italian patients. Cancer. 1998;82:1028–1036
  25. Sasaki Y, Imaoka S, Nakano H, Ishikawa O, Ohigashi H, Yasuda T, et al. Indications for hepatectomy for hepatocellular carcinoma – what stage of the disease is the best indication for surgery?. J Hep Bil Pancr Surg. 1998;5:14–17
  26. Fan ST, Ng IOL, Poon RTP, Lo CM, Liu CL, Wong J. Hepatectomy for hepatocellular carcinoma: the surgeon's role in long-term survival. Arch Surg. 1999;134:1124–1130
  27. Fong Y, Sun RL, Jarnagin W, Blumgart LH. An analysis of 412 cases of hepatocellular carcinoma at a Western center. Ann Surg. 1999;229:790–799
  28. Gouillat C, Manganas D, Saguier D, Duque-Campos R, Berard P. Resection of hepatocellular carcinoma in cirrhotic patients: long-term results of a prospective study. J Am Coll Surg. 1999;189:282–290
  29. Huang YH, Wu JC, Chau GY, Lui WY, King KL, Chiang JH, et al. Supportive treatment, resection and transcatheter arterial chemoembolization in resectable hepatocellular carcinoma: an analysis of survival in 419 patients. Eur J Gastroenterol Hepatol. 1999;11:315–321
  30. Hanazaki K, Kajikawa S, Shimozawa N, Mihara M, Shimada K, Hiraguri M, et al. Survival and recurrence after hepatic resection of 386 consecutive patients with hepatocellular carcinoma. J Am Coll Surg. 2000;191:381–388
  31. Takano S, Watanabe Y, Ohishi H, Kono S, Nakamura M, Kubota N, et al. Multimodality treatment for patients with hepatocellular carcinoma: a single institution retrospective series. Eur J Surg Oncol. 2000;26:67–72
  32. Grazi GL, Ercolani G, Pierangeli F, et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg. 2001;234:71–78
  33. Nagasue N, Ono T, Yamanoi A, et al. Prognostic factors and survival after hepatic resection for hepatocellular carcinoma with cirrhosis. Br J Surg. 2001;88:515–522
  34. Poon RTP, Fan ST, Lo CM, et al. Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg. 2001;234:63–70
  35. Belghiti J, Regimbeau JM, Durand F, Kianmanesh AR, Dondero F, Terris B, et al. Resection of hepatocellular carcinoma: a European experience of 328 cases. Hepatogastroenterology. 2002;49:41–46
  36. Kanematsu T, Furui J, Yanaga K, Okudaira S, Shimada M, Shirabe K. A 16-year experience in performing hepatic resection in 303 patients with hepatocellular carcinoma: 1985–2000. Surgery. 2002;131:S153–S158
  37. Ueno S, Tanabe G, Nuruki K, Oketani M, Komorizono Y, Hokotate H, et al. Prognosis of hepatocellular carcinoma associated with Child class B and C cirrhosis in relation to treatment: a multivariate analysis of 411 patients at a single center. J Hepatobiliary Pancreat Surg. 2002;9:469–477
  38. Wayne JD, Lauwers GY, Ikai I, Doherty DA, Belghiti J, Yamaoka Y, et al. Preoperative predictors of survival after resection of small hepatocellular carcinomas. Ann Surg. 2002;235:722–731
  39. Yeh CN, Chen MF, Lee WC, Jeng LB. Prognostic factors of hepatic resection for hepatocellular carcinoma with cirrhosis: univariate and multivariate analysis. J Surg Oncol. 2002;81:195–202
  40. Ziparo V, Balducci G, Lucandri G, Mercantini P, Di Giacomo G, Fernandes E. Indications and results of resection for hepatocellular carcinoma. Eur J Surg Oncol. 2002;28:723–728
  41. Chen MF, Tsai HP, Jeng LB. Prognostic factors after resection for hepatocellular carcinoma in noncirrhotic livers: univariate and multivariate analysis. World J Surg. 2003;27:443–447
  42. Sim HG, Ooi LLPJ. Results of resections for hepatocellular in a new hepatobiliary unit. ANZ J Surg. 2003;73:8–13
  43. Chen XP, Qiu FZ, Wu ZD, Zhang ZX. Chinese experience with hepatectomy for huge hepatocellular carcinoma. Br J Surg. 2004;91:322–326
  44. Liu JH, Chen PW, Asch SM, Busuttil RW, Ko CY. Surgery for hepatocellular carcinoma: does it improve survival?. Ann Surg Oncol. 2004;11:298–303
  45. Lang H, Sotiropoulos GC, Dömland M, Frühauf NR, Paul A, Hüsing J, et al. Liver resection for hepatocellular carcinoma in non-cirrhotic liver without underlying viral hepatitis. Br J Surg. 2005;92:198–202
  46. Montorsi M, Santambrogio R, Bianchi P, Donadon M, Moroni E, Spinelli A, et al. Survival and recurrences after hepatic resection or radiofrequency for hepatocellular carcinoma in cirrhotic patients: a multivariate analysis. J Gastrointest Surg. 2005;9:62–67
  47. Teh SH, Christein J, Donohue J, Que F, Kendrick M, Farnell M, et al. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: model of end-stage live disease (MELD) score predicts perioperative mortality. J Gastrointest Surg. 2005;9:1207–1215
  48. Wu CC, Cheng SB, Ho WM, Chen JT, Liu TJ, P'eng FK. Liver resection for hepatocellular carcinoma in patients with cirrhosis. B J Surg. 2005;92:348–355
  49. John AR, Khan S, Mirza DF, Mayer AD, Buckells JAC, Bramhall SR. Multivariate and univariate analysis of prognostic factors following resection in HCC: the Birmingham experience. Dig Surg. 2006;23:103–109
  50. Takayama T, Makuuchi M, Hirohashi S, Sakamoto M, Yamamoto J, Shimada K, et al. Early hepatocellular carcinoma as an entity with a high rate of surgical cure. Hepatology. 1998;28:1241–1246
  51. Wu CC, Ho WL, Lin MC, Yeh DC, Wu HS, Hwang CJ, et al. Hepatic resection for bilobar multicentric hepatocellular carcinoma: is it justified?. Surgery. 1998;123:270–277
  52. Liu CL, Fan ST, Lo CM, Poon RT, Wong J. Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg. 2000;232:25–31
  53. Makino Y, Yamanoi A, Kimoto T, El-Assai ON, Kohno H, Nagasue N. The influence of perioperative blood transfusion of intrahepatic recurrence after curative resection of hepatocellular carcinoma. Am J Gastroenterol. 2000;95:1294–1300
  54. Poon RT, Fan ST, Ng IO, Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma: a critical reappraisal. Ann Surg. 2000;231:544–551
  55. Poon RT, Fan ST, Lo CM, Liu CL, Ng IO, Wong J. Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol. 2000;18:1094–1101
  56. Poon RT, Fan ST, Ng IO, Lo CM, Liu CL, Wong J. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer. 2000;89:500–507
  57. Tsai TJ, Chau GY, Lui WY, Tsay SH, King KL, Loong CC, et al. Clinical significance of microscopic tumor venous invasion in patients with resectable hepatocellular carcinoma. Surgery. 2000;127:603–608
  58. Bilimoria MM, Lauwers GY, Doherty DA, Nagorney DM, Belghiti J, Do KA, et al. Underlying liver disease, not tumour factors, predicts long-term survival after resection of hepatocellular carcinoma. Arch Surg. 2001;136:528–535
  59. Hanazaki K, Kajikawa S, Shimozawa N, Shimada K, Hiraguri M, Koide N, et al. Hepatic resection for hepatocellular carcinoma in the elderly. J Am Coll Surg. 2001;192:38–46
  60. Yamamoto J, Okada S, Shimada K, Okusaka T, Yamasaki S, Ueno H, et al. Treatment strategy for small hepatocellular carcinoma: comparison of long-term results after percutaneous ethanol injection therapy and surgical resection. Hepatology. 2001;34:707–713
  61. Zhou XD, Tang ZY, Yang BH, Lin ZY, Ma ZC, Ye SL, et al. Experience of 1000 patients who underwent hepatectomy for small hepatocellular carcinoma. Cancer. 2001;91:1479–1486
  62. Poon RT, Fan ST, Wong J. Selection criteria for hepatic resection in patients with large hepatocellular carcinoma larger than 10 cm in diameter. J Am Coll Surg. 2002;236:602–611
  63. Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo AP. Predictors and patterns of recurrence after resection of hepatocellular carcinoma. J Am Coll Surg. 2003;197:753–758
  64. Ercolani G, Grazi GL, Ravaioli M, Del Gaudio M, Gardini A, Cescon M, et al. Liver resection for hepatocellular carcinoma on cirrhosis: univariate and multivariate analysis of risk factors for intrahepatic recurrence. Ann Surg. 2003;237:536–543
  65. Grazi GL, Cescon M, Ravaioli M, Ercolani G, Gardini A, Del Gaudio M, et al. Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre. Aliment Pharmacol Ther. 2003;17(Suppl. 2):119–129
  66. Kubo S, Taukamoto T, Hirohashi K. Appropriate surgical management of small hepatocellular carcinomas in patients infected with hepatitis C virus. World J Surg. 2003;27:437–442
  67. Lang BHH, Poon RTP, Fan ST, Wong J. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis. Arch Surg. 2003;138:1207–1213
  68. Liu CL, Fan ST, Lo CM, Ng ION, Poon RTP, Wong J. Hepatic resection for bilobar hepatocellular carcinoma. Arch Surg. 2003;138:100–104
  69. Minagawa M, Makuuchi M, Takayama T, Kokudo N. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma. Ann Surg. 2003;238:703–710
  70. Poon RT, Fan ST, Ng IOL, Wong J. Prognosis after hepatic resection for stage IVA hepatocellular carcinoma. Ann Surg. 2003;237:376–383
  71. Wakai T, Shirai Y, Yokoyama N, Nagakura S, Hatakeyama K. Hepatitis virus status affects the pattern of intrahepatic recurrence after resection for hepatocellular carcinoma. Eur J Surg Oncol. 2003;29:266–271
  72. Wei AC, Poon RTP, Fan ST, Wong J. Risk factors for perioperative morbidity and mortality after extended hepatectomy for hepatocellular carcinoma. Br J Surg. 2003;90:33–41
  73. Yeh CN, Lee WC, Chen MF. Hepatic resection and prognosis for patients with hepatocellular carcinoma larger than 10 cm: two decades of experience at Chang Gung memorial hospital. Ann Surg Oncol. 2003;10:1070–1076
  74. Ikai I, Arii S, Kojiro M, Ichida T, Makuuchi M, Matsuyama Y, et al. Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese Nationwide survey. Cancer. 2004;101:796–802
  75. Regimbeau JM, Abdalla EK, Vauthey JN, Lauwers GY, Durand F, Nagorney DM, et al. Risk factors for early death due to recurrence after liver resection for hepatocellular carcinoma: results of a multicenter study. J Surg Oncol. 2004;85:36–41
  76. Hasegawa K, Kokudo N, Imamura H, Matsuyama Y, Aoki T, Minagawa M, et al. Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg. 2005;242:252–259
  77. Huang YH, Wu JC, Chen CH, Chang TT, Lee PC, Chau GY, et al. Comparison of recurrence after hepatic resection in patients with hepatitis B vs. hepatitis C-related small hepatocellular carcinoma in hepatitis B virus endemic area. Liver Int. 2005;25:236–241
  78. Ng KK, Vauthey JN, Pawlik TM, Lauwers GY, Regimbeau JM, Belghiti J, et al. Is hepatic resection for large or multinodular hepatocellular carcinoma justified? Results from a multi-institutional database. Ann Surg Oncol. 2005;12:364–373
  79. Pawlik TM, Poon RT, Abdalla EK, Zorzi D, Ikai I, Curley SA, et al. Critical appraisal of the clinical and pathologic predictors of survival after resection of large hepatocellular carcinoma. Arch Surg. 2005;140:450–457
  80. Pawlik TM, Poon RT, Abdalla EK, Ikai I, Nagorney DM, Belghiti J, et al. Hepatectomy for hepatocellular carcinoma with major portal or hepatic vein invasion: results of a multicenter study. Surgery. 2005;137:403–410
  81. Liu CL, Fan ST, Cheung ST, Lo CM, Ng IO, Wong J. Anterior approach versus conventional approach to right hepatic resection for hepatocellular carcinoma. Ann Surg. 2006;244:194–203
  82. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann Surg. 2006;243:229–235
  83. Sasaki Y, Yamada T, Tanaka H, et al. Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma. Ann Surg. 2006;244:771–780
  84. Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J Am Coll Surg. 2006;202:275–283
  85. Bismuth H, Chiche L, Adam R, Castaing D, Diamond T, Dennison A, et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhosis:. Ann Surg. 1993;218:145–151
  86. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, et al. Liver transplantation for hepatocellular carcinoma: expansion of tumour size limits does not adversely impact survival. Hepatology. 2001;33:1394–1403
  87. Yao FY, Bass NM, Nikolai B, et al. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl. 2002;8:873–883
  88. Wiesner R, Edwards E, Freeman R, et al. The model for end-stage liver disease (MELD), allocation of donor livers. Gastroenterology. 2003;124:91–96
  89. Wiesner R, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology. 2004;127:S261–S267
  90. Barbara L, Benzi G, Gaiani S, Fusconi F, Zironi G, Siringo S, et al. Natural history of small untreated hepatocellular carcinoma in cirrhosis: a multivariate analysis of prognostic factors of tumour growth rate and patient survival. Hepatology. 1992;16:132–137
  91. Cheng SJ, Freemna RB, Wong JB. Predicting the probability of progression-free survival in patients with small hepatocellular carcinoma. Liver Transpl. 2002;8:323–328
  92. Sharma P, Balan V, Hernandez JL, et al. Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl. 2004;10:36–41
  93. Beavers KL, Sandler RS, Shrestha R. Donor morbidity associated with right lobectomy for living donor transplantation to adult recipients: a systemic review. Liver Transpl. 2002;8:110–117
  94. Pascher A, Sauer IM, Walter M, Lopez-Haeninnen E, Theruvath T, Spinelli A, et al. Donor evaluation, donor risks, donor outcome, and donor quality of life in adult-to-adult living donor liver transplantation. Liver Transpl. 2002;8:829–837
  95. Kim-Schluger L, Flormna SS, Schiano . Donor quality of life after adult liver transplant donation. Transplantation. 2004;73:1593–1597
  96. Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A, et al. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology. 2001;33:1073–1079
  97. Cheng SJ, Pratt DS, Freeman RB, Kaplan MM, Wong JB. Living donor vs cadaver for HCC liver transplant for non-resectable small HCC and compensated cirrhosis: a decision analysis. Transplantation. 2001;72:861–868
  98. Roberts JP. Role of adult living donation in patients with hepatocellular carcinoma. Liver Transpl. 2003;9:S60–S63
  99. Kulic L, Abecassis M. Living donor liver transplantation for hepatocellular carcinoma. Gatroenterology. 2004;127:S277–S282
  100. Colella G, De Carlis L, Rondinara GF, Sansalone CV, Belli LS, Aseni P, et al. Is hepatocellular carcinoma in cirrhosis an actual indication for liver transplantation?. Transplant Proc. 1997;29:492–494
  101. Ackar JP, Araya V, Baron RL, Wallis Marsh J, Dvorchik I, Rakela J. Undetected hepatocellular carcinoma: clinical features and outcome after liver transplantation. Liver Transpl Surg. 1998;4:477–482
  102. Bechstein WO, Guckelberger O, Kling N, Rayes N, Tullius SG, Lobeck H, et al. Recurrence-free survival after liver transplantation for small hepatocellular carcinoma. Transpl Int. 1998;11(Suppl. 1):S189–S192
  103. Llovet JM, Bruix J, Fuster J, Castells A, Garcia-Valdecasas JC, Grande L, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology. 1998;27:1572–1577
  104. Chui AK, Rao AR, McCaughan GW, Waugh R, Verran DJ, Koorey D, et al. Liver transplantation for hepatocellular carcinoma in cirrhotic patients. Aust N Z J Surg. 1999;69:798–801
  105. Iwatsuki S, Dvorchik I, Marsh JW, Madariaga JR, Carr B, Fung JJ, et al. Liver transplantation for hepatocellular carcinoma: proposal of a prognostic scoring system. J Am Coll Surg. 2000;191:389–394
  106. Jeng LB, Lee WC, Hung CM, Yu MC, Lee CS, Chien RN, et al. Liver transplantation for hepatocellular carcinoma. Transplant Proc. 2000;32:2171–2172
  107. Figueras J, Ibañez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, et al. Selection criteria for liver transplantation in early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl. 2001;10:877–883
  108. Ghobrial RM, Shimoda M, Farmer DG, Yersiz H, Chen P, Dawson S, et al. Factors determining outcome of liver transplantation for hepatocellular carcinoma associated with hepatitis C cirrhosis. Transplant Proc. 2001;33:1358
  109. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg. 2001;233:652–659
  110. Herrero JI, Sangro B, Quiroga J, Pardo F, Herraiz M, Cienfuegos JA, et al. Influence of tumor characteristics on the outcome of liver transplantation among patients with liver cirrhosis and hepatocellular carcinoma. Liver Transpl. 2001;7:631–636
  111. Jonas S, Bechstein WO, Steinmüller T, Herrmann M, Radke C, Berg T, et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology. 2001;33:1080–1086
  112. Regalia E, Coppa J, Pulvirenti A, Romito R, Schiavo M, Burgoa L, et al. liver transplantation for small hepatocellular carcinoma in cirrhosis: analysis of our experience. Transpl Proc. 2001;33:1442–1444
  113. Tamura S, Kato T, Berho M, Misiakos EP, O'Brien C, Reddy KR, et al. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation. Arch Surg. 2001;233:652–659
  114. Gondolesi G, Muñoz L, Matsumoto C, Fishbein T, Sheiner P, Emre S, et al. Hepatocellular carcinoma: a prime indication for living donor transplantation. J Gastrointest Surg. 2002;6:102–107
  115. Margarit C, Charc R, Hidalgo G, Allende H, Castells L, Bilbao I. Liver transplantation for malignant diseases: selection and pattern of recurrence. World J Surg. 2002;26:257–263
  116. Molmenti EP, Klintmalm GB. Liver transplantation in association with hepatocellular carcinoma: an update of the International tumor registry. Liver Transpl. 2002;9:736–748
  117. Moya A, Berenguer M, Aguilera V, Juan FS, Nicolás D, Pastor M, et al. Hepatocellular carcinoma: can it be considered a controversial indication for liver transplantation in centers with high rates of hepatitis C?. Liver Transpl. 2002;8:1020–1027
  118. Roayaie S, Frischer JS, Emre SH, Fishbein TM, Sheiner PA, Sung M, et al. Long-term results with multimodal adjuvant therapy and liver transplantation for the treatment of hepatocellular carcinomas larger than 5 centimeters. Ann Surg. 2002;235:533–539
  119. Steinmüller T, Pascher A, Sauer IM, et al. Living-donation liver transplantation for hepatocellular carcinoma: time to drop the limitations?. Transplant Proc. 2002;34:2263–2264
  120. Vivarelli M, Bellusci R, Cucchetti A, et al. Low recurrence rate of hepatocellular carcinoma after liver transplantation: better patient selection or lower immunosuppression?. Transplantation. 2002;74:1746–1751
  121. Fernández JA, Robles R, Marin C, et al. Can we expand the indications for liver trasnsplantation amng hepatocellular carcinoma patients with increased tumor size?. Transpl Proc. 2003;35:1818–1820
  122. González-Uriarte J, Valdvieso A, Gastaca M, et al. Liver transplantation for hepatocellular carcinoma in cirrhosis. Transplant Proc. 2003;35:1827–1829
  123. Graziadei IW, Sandmuller H, Waldenberger P, et al. chemoembolization followed by liver transplantation for hepatocellular carcinoma impedes tumor progression while on the waiting list and leads to excellent outcome. Liver Transpl. 2003;9:557–563
  124. Kaihara S, Kiuchi T, Ueda M, et al. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation. 2003;75:S37–S40
  125. Khakhar A, Solano E, Stell D, et al. Survival after liver transplantation for hepatocellular carcinoma. Transplant Proc. 2003;35:2438–2441
  126. Nart D, Arikan C, Akyildiz M, et al. Hepatocellular carcinoma in liver transplant era: a clinicopathologic analysis. Transplant Proc. 2003;35:2986–2990
  127. Sabordio BP, Segurola CL, Calvo AG, et al. Liver transplantation for hepatocellular carcinoma: our experience from 1986. Transplant Proc. 2003;35:1825–1826
  128. Stadlbauer V, Schaffellner S, Kniepeiss D, et al. Experiences in liver transplantation for hepatocellular carcinoma. Transplant Proc. 2004;36:194–198
  129. Andriulli A, di Sio I, Solmi L, et al. Survival of cirrhotic patients with early hepatocellular carcinoma treated by percutaneous ethanol injection or liver transplantation. Liver Transpl. 2004;10:1355–1363
  130. Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg. 2004;239:150–159
  131. Gondolesi G, Roayiae S, Muñoz L, et al. Adult living donor liver transplantation for patients with hepatocellular carcinoma: extending UNOS priority criteria. Ann Surg. 2004;239:142–149
  132. Leung JY, Zhu AX, Gordon FD, Pratt DS, Mithoefer A, Garrigan K, et al. Liver transplantation outcomes for early-stage hepatocellular carcinoma: results of a multicenter study. Liver Transpl. 2004;10:1343–1354
  133. Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2004;10:440–447
  134. Ravaioli M, Ercolani G, Cescon M, Vetrone G, Voci C, Grigioni WF, et al. Liver transplantation for hepatocellular carcinoma: further considerations on selection criteria. Liver Transpl. 2004;10:1195–1202
  135. Shetty K, Timmins K, Brensinger C, Furth EE, Rattan S, Sun W, et al. Liver transplantation for hepatocellular carcinoma validation of present selection criteria in predicting outcome. Liver Transpl. 2004;10:911–918
  136. Shimoda M, Ghobrial RM, Carmody IC, Anselmo DM, Farmer DG, Yersiz H, et al. Predictors of survival after liver transplantation for hepatocellular carcinoma associated with hepatitis C. Liver Transpl. 2004;10:1478–1486
  137. Todo S Furukawa H on behalf of the Japanese study group on organ transplantation. Living donor liver transplantation for adult patients with hepatocellular carcinoma: experience in Japan. Ann Surg. 2004;240:451–461
  138. Yedibela S, Förtsch T, Hohenberger W, Meyer T. Liver transplantation for hepatocellular carcinoma: a single European experience. Langenbecks Arch Surg. 2004;389:104–109
  139. Axelrod D, Koffron A, Kulik L, Al-Saden P, Mulcahy M, Baker T, et al. Living donor transplant for malignancy. Transplantation. 2005;79:363–366
  140. Benckert C, Jonas S, Thelen A, Spinelli A, Schumacher G, Heise M, et al. Liver transplantation for hepatocellular carcinoma in cirrhosis: prognostic parameters. Transpl Proc. 2005;37:1693–1694
  141. Hwang S, Lee SG, Joh KW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver transplantations. Liver Transpl. 2005;11:1265–1272
  142. Island ER, Pomposelli J, Pomfret EA, Gordon FD, Lewis WD, Jenkins RL. Twenty-year experience with liver transplantation for hepatocellular carcinoma. Arch Surg. 2005;140:353–358
  143. Löhe F, Angele MK, Gerbes AL, Löhrs U, Jauch KW, Schauer RJ. Tumour size is an important predictor for the outcome after liver transplantation for hepatocellular carcinoma. Eur J Surg Oncol. 2005;31:994–999
  144. Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, et al. Predictors for long-term survival after transplantation for hepatocellular carcinoma. Am J Gastroentreol. 2005;100:2708–2716
  145. Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation. 2006;81:1532–1541
  146. Malagó M, Sotiropoulos GC, Nadalin S, Valentin-Gamazo C, Paul A, Lang H, et al. Living donor liver transplantation for hepatocellular carcinoma: a single-center preliminary report. Liver Transpl. 2006;12:934–940
  147. Pérez de Luque D, López Vallejos P, Montero Alvarez JL, Fraga Rivas E, Barrera Baena P, Costán Rodero G, et al. Survival of patients receiving a liver transplant for hepatocellular carcinoma, and risk of tumor recurrence. Rev Esp Enferm Dig. 2006;98:899–906
  148. Takada Y, Ueda M, Ito T, Sakamoto S, Haga H, Maetani Y, et al. Living donor liver transplantation as a second-line therapeutic strategy for patients with hepatocellular carcinoma. Liver Transpl. 2006;12:912–919
  149. Marsh JW, Dvorchik I, Subotin M, Balan V, Rakela J, Popechitelev EP, et al. The prediction of risk of recurrence and time of recurrence of hepatocellular carcinoma after orthotopic liver transplantation: a pilot study. Hepatology. 1997;26:444–450
  150. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, et al. Recurrence of hepatocellular carcinoma after transplant: patterns and prognosis. Liver Transpl. 2004;10:534–540
  151. Merli M, Nicolini G, Gentili F, Novelli G, Iappelli M, Casciaro G, et al. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc. 2005;37:2535–2540
  152. Vivarelli M, Cucchetti A, Piscaglia F, La Barba G, Bolondi L, Cavallari A, et al. Analysis of risk factors for tumor recurrence after liver transplantation: key role of immunosuppression. Liver Transpl. 2005;11:497–503
  153. Michel J, Suc B, Montpeyroux F, Hachemanne S, Blanc P, Domergue J, et al. Liver resection or transplantation for hepatocellular carcinoma? Retrospective analysis of 215 patients with cirrhosis. J Hepatol. 1997;26:1274–1280
  154. Colella G, Bottelli R, De Carlis L, Sansalone CV, Rondinara GF, Alberti A, et al. Hepatocellular carcinoma: comparison between liver transplantation, resective surgery, ethanol injection, and chemoembolization. Transplant Int. 1999;11(Suppl. 1):S193–S196
  155. Mazziotti A, Grazi GL, Cavallari A. Surgical treatment of hepatocellular carcinoma on cirrhosis: a Western experience. Hepatogastroenterol. 1998;45(Suppl. 3):1281–1287
  156. Philosophe B, Greig PD, Hemming AW, Cattral MS, Wanless I, Rasul I, et al. Surgical management of hepatocellular carcinoma: resection or transplantation. J Gastrointest Surg. 1998;2:21–27
  157. Rose AT, Rose DM, Pinson CW, Wright JK, Blair T, Blanke C. Hepatocellular carcinoma outcomes based on indicated treatment strategy. Am Surg. 1998;64:1128–1134
  158. Sangro B, Herráiz M, Martínez-González MA, Bilbao I, Herrero I, Beloqui O, et al. Prognosis of hepatocellular carcinoma in relation to treatment: a multivariate analysis of 178 patients from a single European institution. Surgery. 1998;124:575–583
  159. El-Gazzaz G, Wong W, El-Hadary MK, Gunson BK, Mirza DF, Mayer AD, et al. Outcome of liver resection and transplantation fro fibrolamellar hepatocellular carcinoma. Transplant Int. 2000;13(Suppl. 1):S406–S409
  160. Figueras J, Ibañez L, Ramos E, Jaurrieta E, Ortiz-de-Urbina J, Pardo F, et al. Selection criteria for liver transplantation in early-stage hepatocellular carcinomas with cirrhosis: results of a multicenter study. Liver Transpl. 2001;7:877–883
  161. Christians KK, Pitt HA, Rilling WS, Franco J, Quiroz FA, Adams MB, et al. Hepatocellular carcinoma: multimodality management. Surgery. 2001;230:554–560
  162. Bigourdan JM, Jaeck D, Meyer N, Meyer C, Oussoultzoglou E, Bachellier P, et al. Small hepatocellular carcinoma in child A cirrhotic patients: hepatic resection versus transplantation. Liver Transpl. 2003;9:513–520
  163. De Carlis L, Giacomoni A, Pirotta V, Lauterio A, Slim AO, Sammartino C, et al. Surgical treatment of hepatocellular carcinoma in the era of hepatic transplantation. J Am Coll Surg. 2003;196:887–897
  164. Shabahang M, Franceschi D, Yamashiki N, Reddy R, Pappas PA, Aviles K, et al. Comparison of hepatic resection and hepatic transplantation in the treatment of hepatocellular carcinoma among cirrhotic patients. Ann Surg Oncol. 2003;9:881–886
  165. Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I. Resection for hepatocellular carcinoma is a good option for Child–Turcotte–Pugh class A patients with cirrhosis who are eligible for transplantation. Liver Transpl. 2005;11:1242–1251
  166. Piere JPEN, Muzikansky A, Tanabe KK, Ott MJ. The outcome of surgical resection versus assignment to the liver transplant waiting list for hepatocellular carcinoma. Ann Surg Oncol. 2005;1:1–9
  167. Majno PE, Sarasin FP, Mentha G, Hadengue A. Primary liver resection and salvage transplantation or primary liver transplantation inpatients with single, small hepatocellular carcinoma and preserved liver function: an outcome-orientated decision analysis. Hepatology. 2000;31:899–906
  168. Poon RT, Fan ST, Lo CM, Liu CL, Wong J. Long-term survival and pattern of recurrence after resection of hepatocellular carcinoma in patients with preserved liver function: implications for a strategy of salvage transplantation. Ann Surg. 2002;235:373–382
  169. Adam R, Azoulay D, Castaing D, Eshkenazy R, Pascal G, Hashizume K, et al. Liver resection as a bridge to transplantation in hepatocellular carcinoma on cirrhosis: a reasonable strategy?. Ann Surg. 2003;238:508–519
  170. Belghiti J, Cortes A, Abdalla EK, Régimbeau JM, Prakash K, Durand F, et al. Resection prior to liver transplantation for hepatocellular carcinoma. Ann Surg. 2003;38:885–893
  171. Sala M, Fuster J, Llovet JM, Navasa M, Solé M, Varela M, et al. High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage transplantation. Liver Transpl. 2004;10:1294–1300
  172. Hu RH, Ho MC, Wu YM, Yu Sc, Lee PH. Feasibility of salvage liver transplantation for patients with recurrent hepatocellular carcinoma. Clin Transplant. 2005;19:175–180
  173. Cha CH, Ruo L, Fong Y, Jarnagin WR, Shia J, Blumgart LH, et al. Resection of hepatocellular carcinoma in patients otherwise eligible for transplantation. Ann Surg. 2003;238:315–321
  174. Fontana RJ, Hamidullah H, Nghiem H, Greenson JK, Hussain H, Marrero J, et al. Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation. Liver Transpl. 2002;8:1165–1174
  175. Maddala YK, Stadheim L, Andrews JC, Burgart LJ, Rosen CB, Kremers WK, et al. Drop-out rates of patients with hepatocellular carcinoma listed for liver transplantation: outcome with chemoembolization. Liver Transpl. 2004;10:449–455
  176. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, Meyer C, Gugenheim J, Durand F, et al. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl. 2006;12:1761–1769
  177. Yao FY, Hirose R, LaBerge JM, Davern TJ, Bass NM, Kerlan RK, et al. A prospective study of down-staging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005;11:1505–1514
  178. Arii S, Yamaoka Y, Futagawa S, Inoue K, Kobayashi K, Kojiro M, et al. Results of surgical and nonsurgical treatment of small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan. Hepatology. 2000;32:1224–1229
  179. Mathurin P, Raynard B, Dharancy S, Kirzin S, Fallik D, Pruvot FR, et al. Meta-analysis: evaluation of adjuvant therapy after curative liver resection for hepatocellular carcinoma. Aliment Pharmacol Ther. 2003;17:1247–1261
  180. Sun HC, Tang ZY, Wang L, Qin LX, Ma ZC, Ye QH, et al. Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomised controlled trial. J Cancer Res Clin Oncol. 2006;132:458–465
  181. Nishiguchi S, Tamori A, Kubo S. Effect of long-term postoperative interferon therapy on intrahepatic recurrence and survival after resection of hepatitis C virus-related hepatocellular carcinoma. Intervirology. 2005;48:71–75
  182. Lau WY, Leung TW, Ho SK, Chan M, Machin D, Lau J, et al. Adjuvant inter-arterial iodine-131-labelled lipiodol for resectable hepatocellular carcinoma: a prospective randomised trial. Lancet. 1999;353:797–801
  183. Esnaola NF, Mirza N, Lauwers GY, Ikai I, Regimbeau JM, Belghiti J, et al. Comparison of clinicopathologic characteristics and outcomes after resection in patients with hepatocellular carcinoma treated in the United States, France, and Japan. Ann Surg. 2003;238:711–719

PII: S0960-7404(08)00082-0

doi: 10.1016/j.suronc.2008.08.003

Surgical Oncology
Volume 18, Issue 4 , Pages 298-321 , December 2009

Article Tools